Status:
COMPLETED
Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
Lead Sponsor:
Assiut University
Conditions:
Epilepsy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
Evaluate the efficacy of memantine on improving the cognitive impairment in patient with epilepsy
Detailed Description
Epilepsy is a complex disorder, which involves much more than seizures, encompassing a range of associated comorbid health conditions that can have significant health and quality-of-life implications....
Eligibility Criteria
Inclusion
- Patients with idiopathic epilepsy.
- Normal brain imaging (CT brain).
- Patients on anti epileptic drugs more than 6 months.
- No more than two fits per month.
- Score of Mini mental state examination (10-24), mild and moderate cognitive impairment.
- No other medical disorders.
Exclusion
- Progressive neurological diseases.
- Abnormal brain imaging (CT brain).
- More than two fits per month.
- Patients with severe cognitive impairment, score of MMSE less than10.
- Patients with severe medical disorders
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04417543
Start Date
October 1 2018
End Date
January 15 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salma Mohmed Fahmy
Asyut, Egypt